The study on electrochemical behaviors of the interactions between daunorubicin hydrochloride and BSA

Nano Biomedicine and Engineering

Volumn 2, Issue 2, 2010, Pages 138-142

  Liu, Jie ^a   Zhang, Bo ^a  

^a Taiyuan City Centre Hospital   (China)

Author keywords

Bovine serum albumin; Cyclic voltammety; Daunorubicin hydrochloride; Electrochemical behaviors; Linear sweep voltammetry

Indexed keywords

EID: 79955572235     PISSN: None     EISSN: 21505578     Source Type: Journal    
DOI: 10.5101/nbe.v2i2.p138-142     Document Type: Article

References (12)

1. Mayako S, Fadia AK, Kenichi W. Effects of angiotensin II receptor blocker (candesartan) in daunorubicin-induced cardiomyopathic rats. Inter. J. Cardiol. 2006; 110: 378-385
2. Christina L, Linn H, Malin B. Mechanisms of cross-resistance between nucleoside analogues and vincristine or daunorubicin in leukemic cells. Biochem. Biophys. Res.Commun. 2004; 320: 825-832
3. Murphy G, Lawrence W J, and Lenhard R. American Society Textbook of clinical oncology. 2nd Edn., Atlanta: American Cance Society. 1995
4. Erdem A, Ozsoz M. Interaction of the anticancer drug epirubicin with DNA. Analytica Chimica Acta 2001; 437: 107-114
5. Cheng GF, Zhang DM, Ding M, et al. Studies on the interaction of Daunomycin and the specific sequence of DNA. Chem. J. Chin. U. 2003; 24: 1395-1399
6. Madeleine H M, William N J, Beatrice L d'E, et al. DNA-drug interactions: The crystal structure of d(CGATCG) complexed with daunomycin. J. Mol. Biol. 1989; 206: 693-705
7. Haj H T, Salerno M, Priebe W, et al. New findings in the study on the intercalation of bisdaunorubicin and its monomeric analogues with naked and nucleus DNA. Chem-Biol. Interact. 2003; 145: 349-358
8. Lukawska M, Oszczapowicz I, Jelinska A, et al. Development and Validation of RP-HPLC Method for Determination of Novel Derivatives of Daunorubicin. Chem. Anal. 2009; 54: 907-917
9. Lu H, Yuan G, He Q, et al. Rapid analysis of anthracycline antibiotics doxorubicin and daunorubicin by microchip capillary electrophoresis. Microchem. J. 2009; 92: 170-173
10. Celine K, Vanessa T, Juan D R, et al. Mass spectrometric investigation of the DNA-binding properties of an anthracycline with two trisaccharide chains. Arch. Biochem. Biophys. 2008; 477: 348-355
11. Erland JF, Ellen F. Kinetics of anthracycline accumulation in multidrug-resistant tumor cells: relationship to drug lipophilicity and serum albumin binding. Biochem. Pharmacol. 1998; 56: 1209-1217.
12. Ni Y, Sua S, and Serge K. Spectrofluorimetric studies on the binding of salicylic acid to bovine serum albumin using warfarin and ibuprofen as site markers with the aid of parallel factor analysis. Anal. Chim. Acta. 2006; 580: 206-215